Researchers Identify Potential Combination Therapy for Ovarian Cancer

Researchers Identify Potential Combination Therapy for Ovarian Cancer
Melding epigenetic inhibitors with the calpain inhibitor calpeptin may be a promising combination therapy approach to treat ovarian cancer patients, including those who are resistant to platinum-based chemotherapy, a new AntiCancer Research study suggests. The study, “The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells,” revealed that treating ovarian

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *